Michigan Cancer Consortium

Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Shari Ferber Kaufman joins Karmanos Cancer Institute Board of Directors

The Barbara Ann Karmanos Cancer Institute is pleased to announce the election of Shari Ferber Kaufman to its board of directors. Kaufman will serve...

Read More

Karmanos awarded President's Trophy for second year in a row by McLaren Health Care

For the second year in a row, the Barbara Ann Karmanos Cancer Institute has been named the recipient of the President’s Trophy by the McLaren Heal...

Read More

Introducing the new Karmanos.org

The Barbara Ann Karmanos Cancer Institute is excited to announce the launch of the new and improved Karmanos.org website. The new website has easy...

Read More